Top Tweets for #foundationonecdx

over 4 years ago

@Merck @JMDiagn article suggests #TMB using @illumina #TSO500 compares favorably to #FoundationOneCDx in correlation with #WES and clinical utility in predicting pembrolizumab response at cutoff of 10 mut/Mb. https://t.co/Jz9ddBzvvn

Belgian Society of Medical Oncology @mybsmo

over 5 years ago

🧬Friday afternoon, time for @myBSMO weekly #MolecularTumorBoard 👩‍💻👨‍💻 In #GeNeo @myBSMO🤝@Roche_BeLux provides #ComprehensiveGenomicProfiling to 1000 pts with advanced solid tumors #FoundationOneCDx Today we could offer a matched trial option in 🇧🇪to 5/15 pts @aftimosp @OncoAlert

mybsmo's tweet photo. 🧬Friday afternoon, time for @myBSMO weekly #MolecularTumorBoard 👩‍💻👨‍💻
In #GeNeo @myBSMO🤝@Roche_BeLux provides #ComprehensiveGenomicProfiling to 1000 pts with advanced solid tumors #FoundationOneCDx
Today we could offer a matched trial option in 🇧🇪to 5/15 pts @aftimosp @OncoAlert https://t.co/58vph3wyzv

Brian Alexander @xelamb

over 6 years ago

Great blog post and thread on tissue agnostic pembrolizumab approval for #FoundationOneCDx TMB-H tumors. And thanks also to @NCIDirector for calling out the “sustained and successful partnership” between @theNCI and @FoundationATCG.

Dr. Anthony Letai @NCIDirector

over 6 years ago

The recent @US_FDA accelerated tissue-agnostic approval of pembrolizumab is a big deal as it marks another milestone in genomics research and the treatment of cancer. #Genomics #CancerResearch https://t.co/DkorAGbEQn

1stOncology @1stOncology

over 6 years ago

#FoundationMedicine Receives FDA Approval for #FoundationOneCDx as the #CompanionDiagnostic for #Tabrecta™ (#Capmatinib), the Only #FDA-Approved #METInhibitor for Patients With Metastatic #NonSmallCellLungCancer With #METex14 https://t.co/LceIX6Pt54

Top Tweets for #foundationonecdx

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users